Hemoperfusion as an Adjuvant Therapy in Maintenance Hemodialysis Patients with Severe COVID-19: A Single Centre Experience

Hemoperfusion as an Adjuvant Therapy in Maintenance Hemodialysis Patients with Severe COVID-19: A Single Centre Experience

Mortality rate among maintenance hemodialysis (HD) patients with COVID-19 is alarmingly high. In Fatmawati General Hospital, most of HD patients with COVID-19 presented with acute respiratory distress syndrome (ARDS). Hemoperfusion (HP) is a blood purification therapy used to remove cytokines and in...

Full description

Bibliographic Details
Main Authors: Elizabeth Yasmine Wardoyo, Anggraini Permata Sari, Aryan Y Djojo, Johanes Sarwono, Md Ikhsan Mokoagow, Nikko Darnindro, Jerry Nasarudin, Marina Epriliawati, Annela Manurung, Martha Iskandar, Krishna Adi Wibisana, Anak Agung Arie Widyastuti, Radhiyatam Mardiyah
Format: Article
Language:English
Published: Interna Publishing 2022-07-01
Series:Acta Medica Indonesiana
Subjects:
hemoperfusion
hemodialysis
covid-19
cytokines
resin
Online Access:https://actamedindones.org/index.php/ijim/article/view/2039

Internet

https://actamedindones.org/index.php/ijim/article/view/2039

Similar Items